which removes variables from the model if the probability values associated with their effects are larger than or equal to 0.15. The following set of four analyses was done: a) analysis of the total study group with sex, ethnic group (comprising the four main groups in Israeli Jews, those of Yemenite, North African, Mid-Eastern, and European origin), hyperinsulinemia, and the GOH conditions, as well as total triglycerides (assigning a value of 400 mg/dl to 11 cases with extreme values), total cholesterol, and age in their continuous form as the independent variables, including a sex-hyperinsulinemia interaction; b and c) separate analyses of hyperinsulinemic and normoinsulinemic individuals with the same independent variables. In each of these three analyses (a-c), glucose intolerance, obesity, and hypertension were entered into the model once as three separate variables and again as a combined single variable, dividing the study group into three mutually exclusive risk categories: I) individuals with none of the GOH conditions; II) normotensives who were glucose intolerant, obese, or both; and III) all hypertensives. d) Separate analysis of the group of all hypertensives with the same independent variables, including the hyperinsulinemia-sex interaction, and entering glucose intolerance and obesity once as separate variables and once as a single combined variable (i.e., obese and/or glucose intolerant).
In all analyses (a-d) the reported risk ratios pertaining to the GOH conditions, followed by 95% confidence limits in brackets, apply only to the combined variables, because the results using each of the GOH conditions as a separate variable were similar.
This set of analyses was repeated on the subgroup of 681 individuals on whom lipoprotein measurements were available, entering VLDLTG, LDLC, and HDLC in their continuous form as independent variables into the model.
A complementary analysis, using all variables in their continuous form, was analysis of covariance (BMDP program 2V) with log transformed sum insulin as the dependent variable. This was done in the 681 individuals whose lipoproteins were measured, with sex and CVD as grouping factors and with age, BMI, mean systolic blood pressure, sum blood glucose, LDLC, VLDLTG, HDLC, and total cholesterol to HDLC ratio as covariates. Internal comparisons were done using the error mean square. The adjusted logarithmic means of sum insulin are reported in their antilog form. This analysis was repeated three times: once on all 681 individuals, once excluding those on antihypertensive medications, and again in nonsmokers.
Results Sex and CVD The study group comprised 688 men and 575 women, their mean+SD ages being 53 Stratification by all possible combinations of the GOH conditions revealed complex inter-relations between the GOH conditions, hyperinsulinemia, and sex, with respect to their effect on CVD rate (Table  2 and Appendix Table) . This analysis delineated three risk categories: I) This category comprised individuals with none of the GOH conditions. In it, age-adjusted rates of CVD in men compared with women, as well as in normoinsulinemic compared with hyperinsulinemic individuals in each sex, were not significantly different and were all low, 6.5% or less. II) This category comprised all normotensives who were not part of risk category I, and therefore included three subgroups -those with glucose intolerance alone, obesity alone, or both. These subgroups were pooled in the table because of the similarity of CVD rates when stratified by hyperinsulinemia and sex (see Appendix Table for detailed data on each subgroup). In this pooled category, age-adjusted rates of CVD in normoinsulinemic men and women and in hyperinsulinemic women were similar, were also low, (6% or less), and did not differ significantly from the respective rates in risk category I. However, in hyperinsulinemic men in this category, CVD rate was significantly increased more than twofold (15.2%; p=0.04 versus normoinsulinemic men andp=0.015 versus hyperinsulinemic women in the same risk category). III) This category comprised all hypertensives. These were pooled here since CVD rates were not affected by the presence or absence of glucose intolerance or obesity (see Appendix Table  for detailed data) . Here, the normoinsulinemic individuals manifested age-adjusted CVD rates, which were significantly increased more than twofold relative to the normoinsulinemic in risk categories I and II (i.e., normoinsulinemic normotensives), in both men (13.4%) and women (10.4%). In men, this difference was significant (p<0.01). In women, the difference reached significance (p<0.01) only when compared with all normotensive women. The increased rate in normoinsulinemic hypertensives did not differ significantly in men and women. In hyperinsulinemic men, the rate of CVD increased almost twofold relative to those who were normoinsulinemic (21.5% versus 13.4%, p=0.03) as well as relative to hyperinsulinemic women (21.5% versus 10.4%, p=0.03) in the same risk category. In women, however, no significant effect of hyperinsulinemia was noted (12.8% versus 10.4%).
To summarize, this analysis revealed a subgroup that constitutes 35.8% of men and 44.9% of women in our study group (comprising all normoinsulinemic normotensives and hyperinsulinemic individuals free of the GOH conditions) in whom the age-adjusted CVD rate was low (<5%) and similar in both sexes. An additional subgroup manifesting similar rates in both sexes was the normoinsulinemic hypertensives (constituting 20 .5% of men and 18.1% of women), but here the age-adjusted CVD rates were more than twofold higher as compared with the first subgroup. Therefore, all excess CVD risk associated with the male sex was confined to hyperinsulinemic individuals with at least one of the GOH conditions. Based on the data from the 681 individuals on whom complete lipoprotein data were available, there was no indication that disturbed lipoprotein profile accounted for these observations because the same trends were observed among men in whom all lipoprotein fractions were completely normal (as defined in our previous study12); thus, CVD rates among these men were 18.8% in 16 hyperinsulinemic normotensives with glucose intolerance and/or obesity and 20.6% in 34 hyperinsulinemic hypertensives. It is, however, noteworthy in hyperinsulinemic hypertensives who presented a combination of high VLDL, high LDL, and low HDL as defined in our previous study,12 CVD rates were very high and similar in 48 men and The trends demonstrated in Table 2 were corroborated by logistic regression analyses, adjusting for age, ethnic group, and blood lipids (Table 3 ). In normoinsulinemic individuals, hypertension had an independent highly significant effect on CVD rate (p<0.001) with a risk ratio of 2.52 (1.43-4.43) ; sex, as well as glucose intolerance and obesity, alone or in combination, had no significant effect. In hyperinsulinemic individuals each of the factors had a highly significant independent effect: The adjusted risk ratio associated with the male sex was 2.74 (1.74-4.32) (Figure 2) . Insulin response was similar in men free of CVD and in women with or without CVD (133.9, 125.8, and 133.8, respectively). However, it was significantly increased in men with CVD (adjusted mean 162.3, p<0.001). The adjusted means of insulin response by CVD and sex remained practically the same when individuals on antihypertensive medications and smokers were excluded ( Table 4 ), indicating that these factors had no appreciable effect on insulin levels or on their association with CVD.
Discussion
Excess CVD risk in men compared with women is an unequivocally inherent characteristic of this disease. 20 The only exception is diabetes, in which equally high rates have been reported by some but not all investigators.6.26 In our representative sample of a population in the age range of 40-70, the overall prevalence of CVD morbidity in men was double that in women. However, stratification by hyperinsulinemia and the GOH conditions revealed a sizeable category, constituting about 40% of our sample, in whom CVD rate in men was equally low to that in women. These were the normoinsulinemic normotensives as well as the hyperinsulinemic individuals free of the GOH conditions. Moreover, all excess risk of CVD in men was confined to hyperinsulinemic individuals, in whom at least one of the GOH conditions was present.
Three large-scale community-based prospective studies generated the main evidence associating elevated insulin levels with increased risk of ischemic heart disease (IHD) morbidity3 and mortality,2-4 as well as with overall CVD mortality. 4 These studies showed that elevated insulin levels predict this risk after accounting for the effects of age, the GOH conditions, and blood lipid levels. The only one of these studies4 that included women showed that elevated insulin levels were predictive of CVD only in men and is, therefore, consistent with our data. However, in that study CVD rates were not compared in the normoinsulinemic men and women.
It is noteworthy that in our data glucose intolerance or obesity conveyed independent excess CVD risk only in hyperinsulinemic men. There was no indication for a different trend in the newly found diabetes cases, but their number was too small for definite conclusions. Hypertension was the only GOH condition independently associated with excess CVD in normoinsulinemic individuals of both sexes as well as in hyperinsulinemic women, but in men the risk was further enhanced in the presence of hyperinsulinemia. Central adiposity was not measured in our study. Because central adiposity is more prevalent in men27-29 and is positively and independently correlated with hyperinsulinemia/insulin resistance, hypertension, glucose intolerance, and CVD,27-32 it could play a role in our findings. It seems, however, unlikely that it would be the only factor, because this type of adiposity should have been present in the majority of our obese women whose BMI was equal to or more than 27 and most of whom were postmenopausal. 27, 28, 30 Of the three prospective studies, only the Paris Prospective Study of ischemic heart disease mortality risk in men directly analyzed the effects of the interaction of hyperinsulinemia with the GOH conditions on this risk.2 The pattern found was strikingly similar to ours in that significant excess mortality among hyperinsulinemic individuals appeared only in the presence of at least one of the GOH conditions. Also, within their group of normoinsulinemic individuals IHD mortality was increased in hypertensives but not in individuals who were glucose intolerant or obese. Mortality in hyperinsulinemic hypertensives was highest.
Finally, we did not find any clinical pattern of CVD as specifically characterizing hyperinsulinemic men. Asymptomatic electrocardiographic evidence of myocardial ischemia, which constituted 40% of our CVD cases, was associated with hyperinsulinemia in much the same way as overt ischemic heart disease. This association has not been previously reported and is consistent with studies showing that both hyperinsulinemia2-4 and asymptomatic myocardial ischemia3334 preceded overt CVD. Cerebrovascular and peripheral vascular diseases were also increased in the presence of hyperinsulinemia in our men. In the Australian prospective study,4 hyperinsulinemia in men was predictive of total CVD mortality but separate analysis of subcategories was done only for ischemic heart disease. Increased incidence of claudication in hyperinsulinemic individuals, mainly with noninsulin-dependent diabetes, has recently been reported in a small prospective study. 35 The main limitation of our data is that they are cross sectional, but this does not negate the major findings. It is unlikely that the similarly low prevalence of CVD in men and women among normoinsulinemic normotensives and hyperinsulinemic individuals free of the GOH conditions was due to selective mortality. This would imply that men in this risk category had higher mortality than the hyperinsulinemic men with the GOH conditions, contradicting the results of the Paris Prospective Study.2 The potential confounding effect of smoking and use of antihypertensive medications was negated by the similarity of results in the absence of these two factors. The possibility that hyperinsulinemia developed subsequent to the onset of CVD could at most offer only a partial explanation for our results, as evidenced by the results of the prospective studies. [2] [3] [4] The data from the three prospective studies,2-4 as well as cross-sectional epidemiological and clinical studies showing independent correlation of elevated insulin levels and insulin resistance with the GOH conditions and dyslipoproteinemia (elevated VLDL and LDL as well as reduced HDL),11,13-19,36-40 have been interpreted as supporting the putative role of hyperinsulinemia and/or insulin resistance in the atherogenic process. However, the data from our study, the Australian Study,4 and the Paris Prospec-tive Study2 indicate that hyperinsulinemia was not associated with CVD in all women or in men free of the GOH conditions. This suggests that hyperinsulinemia in itself is not atherogenic.
The increased propensity of men to develop CVD is yet to be explained. The inclination has been to ascribe it to the androgenic sex hormone profile. 41, 42 In contrast with the consistent association of CVD with hyperinsulinemia in men, the evidence for its association with androgenic hormone profile is equivocal. Decreased sex hormone binding globulin (SHBG), which reflects higher levels of free testosterone and other androgens, 42 However, in our hyperinsulinemic men with at least one GOH condition, the high CVD risk was not accounted for by lipoprotein profile because the risk remained high even when all lipoprotein fractions were normal. We have previously also demonstrated12 that lipoprotein profile was disturbed to the same extent in hyperinsulinemic individuals in the presence and absence of the GOH conditions. Therefore, our current findings of low CVD rates in hyperinsulinemic men free of the GOH conditions cannot be ascribed to a better lipoprotein profile.
Clearly then, the mechanisms responsible for our findings must be complex and involve additional presently unidentified factors. This notion seems to be supported by the fact that insulin levels were high in our men with CVD, even after adjusting for levels of glucose response, blood pressure, BMI, lipoproteins, and age, suggesting a role for additional factors in this association. Other factors known to be associated with hyperinsulinemia/insulin resistance, as well as with atherosclerosis, could participate in this mechanism. These are vascular smooth muscle proliferation,51-53 increased blood coagulability,54-57 reduced tissue lipoprotein lipase activity,48,58,59 and altered activity of the autonomic nervous system. [60] [61] [62] With the exception of reduced lipoprotein lipase activity in men,63 sex-related differences in these factors have not been reported. However, even if such differences were found, the low CVD rates in all hyperinsulinemic women and in hyperinsulinemic men free of the GOH conditions indicate that such a relation would not be straightforward.
Notwithstanding, the excess CVD risk in men is obviously related in some way to the insulin-resistant state. In this context, it is of interest that significantly lower glucose levels at similar insulin levels have been reported in women compared with men.64 Similar findings were observed in our study group after adjustment for age and BMI. In addition, during the OGTT about 40% of our women compared with only about 20% of the men reattained fasting levels within 1 hour (M. Modan et al, unpublished data). Also, as others29 have found, both insulin and glucose responses to oral glucose load were lower in our women. These findings may reflect greater insulin sensitivity in women, which could account for the lack of association of hyperinsulinemia with CVD in them.
The strong association between all classical pathophysiological risk factors for CVD with each other and with hyperinsulinemia and its attendant insulin resistance has been interpreted to reflect the existence of a syndrome rather than a series of independent factors. 1637 We found a wide range of CVD risk associated with the various combinations of the GOH conditions, hyperinsulinemia, and sex. This seems to indicate that rather than a single syndrome, there appear to be a number of entities with differential CVD risk and divergent etiology. In this context it is of interest to mention the recently identified syndrome of familial dyslipidemic hypertension that is characterized by hyperinsulinemia65 and our finding in the current report, albeit based on small numbers, of excessively high CVD rate in hyperinsulinemic hypertensives with overall disturbed lipoprotein profile of both sexes.
The possible involvement of hyperinsulinemia/insulin resistance in the pathogenesis of CVD has potential implications regarding prevention of this pandemic of industrialized society. Major environmental CVD risk factors are associated with diminished insulin sensitivity. The main evidence relates to excessive total caloric intake7,8,31,37,60 and sedentary life-style.21,60,66-68 Moreover, the Finnish prospective study3 demonstrated negative correlations of physical activity and physical fitness with IHD morbidity and mortality as well as with insulin levels. Therefore, the currently recommended health-promoting lifestyle'0'66'69 may exert its preventive effect on CVD and its risk factors, at least in part, by improving insulin sensitivity.11,37
